NCT03803670View on ClinicalTrials.gov

Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia

CompletedOBSERVATIONAL
Enrollment

241

Participants

Timeline

Start Date

January 1, 2007

Primary Completion Date

January 1, 2019

Study Completion Date

January 10, 2019

Conditions
Acute Lymphoblastic Leukemia
Interventions
DIAGNOSTIC_TEST

evaluation of cerebrospinal fluid of ALL

We evaluated cerebrospinal fluids of patients with ALL by conventional cytology and by flow cytometry

All Listed Sponsors
lead

University of Rome Tor Vergata

OTHER

NCT03803670 - Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter